Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Zile, Michael
Item TypeName
Academic Article Left ventricular length-force-shortening relations before and after surgical correction of chronic mitral regurgitation.
Academic Article The effects of valvular regurgitation on thermodilution ejection fraction measurements.
Academic Article Microtubule depolymerization normalizes in vivo myocardial contractile function in dogs with pressure-overload left ventricular hypertrophy.
Academic Article Randomized trial comparing partial versus complete chordal-sparing mitral valve replacement: effects on left ventricular volume and function.
Academic Article Heart failure in aortic stenosis - improving diagnosis and treatment.
Academic Article Heart failure with preserved ejection fraction: is this diastolic heart failure?
Academic Article Left ventricular function after surgical correction of chronic mitral regurgitation.
Academic Article Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure.
Academic Article Treating diastolic heart failure with statins: "phat" chance for pleiotropic benefits.
Academic Article Left ventricular end-diastolic volume is normal in patients with heart failure and a normal ejection fraction: a renewed consensus in diastolic heart failure.
Academic Article Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial.
Academic Article Mechanical loads and the isovolumic and filling indices of left ventricular relaxation.
Academic Article Cardiopulmonary exercise variables in diastolic versus systolic heart failure.
Academic Article Patterns of structural and functional remodeling of the left ventricle in chronic heart failure.
Academic Article Irbesartan in patients with heart failure and preserved ejection fraction.
Academic Article Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial.
Academic Article Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial.
Academic Article Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE).
Academic Article Natural history of concentric left ventricular geometry in community-dwelling older adults without heart failure during seven years of follow-up.
Academic Article Chronic baroreflex activation: a potential therapeutic approach to heart failure with preserved ejection fraction.
Academic Article Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.
Academic Article Stress-shortening relations and myocardial blood flow in compensated and failing canine hearts with pressure-overload hypertrophy.
Academic Article Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy.
Academic Article Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.
Academic Article Effect of antihypertensive therapy on ventricular-arterial mechanics, coupling, and efficiency.
Academic Article HFpEF: cardiovascular abnormalities not just comorbidities.
Academic Article Depressed contractile function due to canine mitral regurgitation improves after correction of the volume overload.
Academic Article Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction.
Academic Article Contribution of reduced mitral regurgitant volume to vasodilator effect in severe left ventricular failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy.
Academic Article Evaluation of myocardial function in cardiomyopathic states.
Academic Article Native beta-adrenergic support for left ventricular dysfunction in experimental mitral regurgitation normalizes indexes of pump and contractile function.
Academic Article Left ventricular hypertrophy due to volume overload versus pressure overload.
Academic Article Mitral valve replacement with and without chordal preservation in patients with chronic mitral regurgitation. Mechanisms for differences in postoperative ejection performance.
Academic Article Aortic valve resistance as an adjunct to the Gorlin formula in assessing the severity of aortic stenosis in symptomatic patients.
Academic Article Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle.
Academic Article A phase II, double-blind, randomized, placebo-controlled, dose comparative study of the efficacy, tolerability, and safety of MCC-135 in subjects with chronic heart failure, NYHA class II/III (MCC-135-GO1 study): rationale and design.
Academic Article Lack of relationship between Doppler indices of diastolic function and left ventricular pressure transients in patients with definite diastolic heart failure.
Academic Article Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition.
Academic Article The irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial: rationale and design.
Academic Article Chronic heart failure: a report from the Dartmouth Diastole Discourses.
Academic Article Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial.
Academic Article A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
Academic Article Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial.
Academic Article Calpain inhibition preserves myocardial structure and function following myocardial infarction.
Academic Article Distribution of left ventricular ejection fraction in patients with ischemic and hypertensive heart disease and chronic heart failure.
Academic Article Progressive improvement in cardiac performance with continuous aortic flow augmentation (aortic flow therapy) in patients hospitalized with severe heart failure: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM).
Academic Article Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
Academic Article Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction.
Academic Article Assessment of long-term effects of irbesartan on heart failure with preserved ejection fraction as measured by the minnesota living with heart failure questionnaire in the irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial.
Academic Article The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.
Academic Article Effects of exercise on left ventricular systolic and diastolic properties in patients with heart failure and a preserved ejection fraction versus heart failure and a reduced ejection fraction.
Academic Article Comparison of left and right ventricular end-systolic pressure-volume relations in congestive heart failure.
Academic Article Serial changes in left ventricular function after correction of chronic aortic regurgitation. Dependence on early changes in preload and subsequent regression of hypertrophy.
Academic Article Vasodilator effect on right ventricular function in congestive heart failure and pulmonary hypertension: end-systolic pressure--volume relation.
Academic Article Left ventricular mechanics and myocyte function after correction of experimental chronic mitral regurgitation by combined mitral valve replacement and preservation of the native mitral valve apparatus.
Concept Stroke Volume
Academic Article Left ventricular dyssynchrony in patients with heart failure and preserved ejection fraction.
Academic Article Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
Academic Article Randomized, double-blind, placebo-controlled study of sitaxsentan to improve impaired exercise tolerance in patients with heart failure and a preserved ejection fraction.
Academic Article Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction.
Academic Article Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial.
Academic Article Developing therapies for heart failure with preserved ejection fraction: current state and future directions.
Academic Article Baseline characteristics and treatment of patients in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF).
Academic Article Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve).
Academic Article Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial.
Academic Article Impaired left atrial function in heart failure with preserved ejection fraction.
Academic Article Angiotensin-neprilysin inhibition versus enalapril in heart failure.
Academic Article Worsening renal function and outcome in heart failure patients with preserved ejection fraction and the impact of angiotensin receptor blocker treatment.
Academic Article Reply: does speckle tracking really improve diagnosis and risk stratification in patients with HF with normal EF?
Academic Article History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fraction.
Academic Article A prediction model for sudden cardiac death in patients with heart failure and preserved ejection fraction.
Academic Article Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction.
Academic Article Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.
Academic Article International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction.
Academic Article Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin.
Academic Article Characteristics and outcomes of patients with advanced chronic systolic heart failure receiving care at the Veterans Affairs versus other hospitals: insights from the Beta-blocker Evaluation of Survival Trial (BEST).
Academic Article A novel ultrasound predictor of pulmonary capillary wedge pressure assessed by the combination of left atrial volume and function: A speckle tracking echocardiography study.
Academic Article Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction.
Academic Article Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction.
Academic Article Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study.
Academic Article Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction.
Academic Article The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
Academic Article Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
Academic Article Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro-B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
Academic Article Clinical Characteristics and Outcomes of Patients With Coronary Artery Disease and Angina: Analysis of the Irbesartan in Patients With Heart Failure and Preserved Systolic Function Trial.
Academic Article Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response.
Academic Article How B-Type Natriuretic Peptide (BNP) and Body Weight Changes Vary in Heart Failure With Preserved Ejection Fraction Compared With Reduced Ejection Fraction: Secondary Results of the HABIT (HF Assessment With BNP in the Home) Trial.
Academic Article Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study.
Academic Article Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial.
Academic Article Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.
Academic Article Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction.
Academic Article Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-PRESERVE) trial.
Academic Article Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.
Academic Article Influence of Sacubitril/Valsartan (LCZ696)?on?30-Day Readmission After Heart Failure Hospitalization.
Academic Article Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction.
Academic Article Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial.
Academic Article Exploring New Endpoints for Patients With Heart Failure With Preserved Ejection Fraction.
Academic Article Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril: A Secondary Analysis of the PARADIGM-HF Trial.
Academic Article Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction.
Academic Article Impact of Body Mass Index on the Accuracy of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide for Predicting Outcomes in Patients With Chronic Heart Failure and Reduced Ejection Fraction: Insights From the PARADIGM-HF Study (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial).
Academic Article Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction.
Academic Article Could Modification of Titin Contribute to an Answer for Heart Failure With Preserved Ejection Fraction?
Academic Article Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure.
Academic Article Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction.
Academic Article Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction).
Academic Article Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF.
Academic Article Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials.
Academic Article Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients?
Academic Article The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF.
Academic Article Evaluation of systolic and diastolic properties of hypertensive heart failure using speckle-tracking echocardiography with high volume rates.
Academic Article Declining Risk of Sudden Death in Heart Failure.
Academic Article Heart Rate and Outcomes in Hospitalized?Patients With Heart Failure With Preserved Ejection?Fraction.
Academic Article Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.
Academic Article Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy.
Academic Article Type of Atrial Fibrillation and Outcomes in?Patients With Heart Failure and Reduced?Ejection?Fraction.
Academic Article Cardiac macrophages promote diastolic dysfunction.
Academic Article Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).
Academic Article Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure: A Secondary Analysis of the PARADIGM-HF Trial.
Academic Article Incidence, Predictors, and Outcomes Associated With Hypotensive Episodes Among Heart Failure Patients Receiving Sacubitril/Valsartan or Enalapril: The PARADIGM-HF Trial (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure).
Academic Article Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure.
Academic Article Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease.
Academic Article Independent Prognostic Value of Serum Soluble ST2 Measurements in Patients With Heart Failure and a Reduced Ejection Fraction in the PARADIGM-HF Trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure).
Academic Article Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial.
Academic Article Safety and Feasibility of a Nocturnal Heart Rate Elevation-Exploration of a Novel Treatment Concept.
Academic Article Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate.
Academic Article Heart failure with preserved ejection fraction in Asia.
Academic Article First granted example of novel FDA trial design under Expedited Access Pathway for premarket approval: BeAT-HF.
Academic Article Growth differentiation factor-15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trial.
Academic Article IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients With Heart Failure.
Academic Article Bioactive Signaling in Next-Generation Pharmacotherapies for Heart Failure: A Review.
Academic Article Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial.
Academic Article Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas.
Academic Article The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes.
Academic Article Heart Failure With Preserved Ejection Fraction in the Young.
Academic Article Differential Impact of Heart Failure With?Reduced Ejection Fraction on?Men?and?Women.
Academic Article Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial.
Academic Article Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients?With HFrEF.
Academic Article N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status.
Academic Article Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
Academic Article Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF.
Academic Article Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction.
Academic Article Relation of Lymphangiogenic Factor Vascular Endothelial Growth Factor-D to Elevated Pulmonary Artery Wedge Pressure.
Academic Article Health-Related Quality of Life in Heart?Failure With Preserved Ejection?Fraction: The PARAGON-HF Trial.
Academic Article Age-Related Characteristics and Outcomes of Patients With Heart?Failure With Preserved Ejection Fraction.
Academic Article Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
Academic Article Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
Academic Article Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HF.
Academic Article Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF.
Academic Article Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure.
Academic Article Echocardiographic Features of Patients?With Heart?Failure and Preserved?Left Ventricular Ejection Fraction.
Academic Article Sex-Related Differences in Heart Failure With Preserved Ejection Fraction.
Academic Article Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction.
Academic Article The Vexing Problem of HFpEF?Therapeutics: Inching Toward Success.
Academic Article Focusing Heart Failure Research on Myocardial Fibrosis to Prioritize Translation.
Academic Article Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserved ejection fraction (CAPACITY HFpEF).
Academic Article Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart?Failure With Preserved Ejection Fraction.
Academic Article Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
Academic Article Myocardial Infarction in Heart?Failure With Preserved Ejection Fraction: Pooled Analysis of 3 Clinical Trials.
Academic Article Liver function and prognosis, and influence of sacubitril/valsartan in patients with heart failure with reduced ejection fraction.
Academic Article Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Academic Article Natriuretic Peptides as Inclusion Criteria in Clinical Trials: A JACC: Heart?Failure Position Paper.
Academic Article Covariate adjusted reanalysis of the I-Preserve trial.
Academic Article Reply: Different Phenotype Characterization in PARAGON-HF: An Unresolved Puzzle in Patients With HFpEF.
Academic Article The prevalence and importance of frailty in heart failure with reduced ejection fraction?-?an analysis of PARADIGM-HF and ATMOSPHERE.
Academic Article Baroreflex Activation Therapy in Patients With Heart?Failure With Reduced Ejection Fraction.
Academic Article Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart?Failure Cause: A PARADIGM-HF Analysis.
Academic Article Reply: Circulating Biomarkers Specific to Myocardial Extracellular Matrix Are Required to Embrace the Heterogeneity of HFpEF.
Academic Article Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction.
Academic Article Impact of diabetes on serum biomarkers in heart failure with preserved ejection fraction: insights from the TOPCAT trial.
Academic Article Serum potassium and outcomes in heart failure with preserved ejection fraction: a post-hoc analysis of the PARAGON-HF trial.
Academic Article Prevalence and incidence of intra-ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM-HF and ATMOSPHERE.
Academic Article Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF.
Academic Article Serum potassium in the PARADIGM-HF trial.
Academic Article Serum uric acid, influence of sacubitril-valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF.
Academic Article Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: The CAPACITY HFpEF Randomized Clinical Trial.
Academic Article Acute pulmonary pressure change after transition to sacubitril/valsartan in patients with heart failure reduced ejection fraction.
Academic Article Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF.
Academic Article INTERVENE-HF: feasibility study of individualized, risk stratification-based, medication intervention in patients with heart failure with reduced ejection fraction.
Academic Article Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE trials.
Academic Article Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan: Insights From a Combined PARAGON-HF and PARADIGM-HF Analysis.
Academic Article Global Differences in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial.
Academic Article Influence of study discontinuation during the run-in period on the estimated efficacy of sacubitril/valsartan in the PARAGON-HF trial.
Academic Article Treatment Effects of Sacubitril/Valsartan Compared With Valsartan by Ejection Fraction in Patients With Recent Hospitalization.
Academic Article Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction.
Academic Article A Targeted Treatment Opportunity for HFpEF: Taking Advantage of Diastolic Tone.
Academic Article Pragmatic Weight Management Program for Patients With Obesity and Heart Failure With Preserved Ejection Fraction.
Academic Article From Systemic Inflammation to Myocardial Fibrosis: The Heart Failure With Preserved Ejection Fraction Paradigm Revisited.
Academic Article Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and ATMOSPHERE.
Academic Article Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM-HF trial.
Academic Article Integrating High-Sensitivity Troponin T and?Sacubitril/Valsartan Treatment in?HFpEF: The PARAGON-HF Trial.
Academic Article Prognostic Value of Minimal Left Atrial Volume in Heart Failure With Preserved Ejection Fraction.
Academic Article Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON-HF.
Academic Article Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction.
Academic Article Natriuretic peptide-based inclusion criteria in heart failure with preserved ejection fraction clinical trials: insights from PARAGON-HF.
Academic Article Atrial Fibrillation in Heart?Failure With Preserved Ejection Fraction: The PARAGON-HF Trial.
Academic Article Clinical Outcomes Related to Background Diuretic Use and New Diuretic Initiation in Patients With HFrEF.
Academic Article Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HF.
Academic Article Angiotensin-neprilysin inhibition and renal outcomes across the spectrum of ejection fraction in heart failure.
Academic Article Diastolic Dysfunction With Preserved Ejection Fraction After the Fontan Procedure.
Academic Article Ensemble machine learning model identifies patients with HFpEF from matrix-related plasma biomarkers.
Academic Article Baroreflex activation therapy with the Barostim? device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials.
Academic Article Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials.
Academic Article Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction.
Academic Article Hemodynamically-Guided Management of Heart?Failure Across the Ejection?Fraction Spectrum: The GUIDE-HF Trial.
Academic Article Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction.
Academic Article Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation.
Academic Article Aptamer Proteomics for Biomarker Discovery in Heart Failure With Reduced Ejection Fraction.
Academic Article Associations Between New York Heart Association Classification, Objective Measures, and Long-term Prognosis in Mild Heart Failure: A Secondary Analysis of the PARADIGM-HF Trial.
Academic Article Urinary cGMP (Cyclic Guanosine Monophosphate)/BNP (B-Type Natriuretic Peptide) Ratio, Sacubitril/Valsartan, and Outcomes in Heart Failure With Reduced Ejection Fraction: An Analysis of the PARADIGM-HF Trial.
Search Criteria
  • Stroke Volume